ACE then hydrolyzes AT-1 by cleaving the carboxyl terminal His-Leu dipeptide from the inactive AT-1 to the active angiotensin II (AT-2), a potent vasoconstrictor responsible for the development of hypertension [5,6,11,12]. The gene discussed is ACE; the disease is hypertensive disorder.